Concepedia

Hong‐Tu Zhang

HZ

Statistics

Publications

15

Citations

698

H-Index

12

Active since

2007

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Peking Union Medical College Hospital

Chinese Academy of Sciences

University of Zurich

Martin Luther University Halle-Wittenberg

Hong‐Tu Zhang is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, oncology, and neoplasia.

ORCID

Publications per year

2007–2024

15

Publications

15

Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma

Jing Huang, Binghe Xu, Hongnan Mo et al. · Clinical Cancer Research · 2018 · 217 citations

, , +17

Treatment options in stage I endometrial stromal sarcoma: A retrospective analysis of 53 cases

Ning Li, Lingying Wu, Hong‐Tu Zhang et al. · Gynecologic Oncology · 2007 · 88 citations

, , +8

A phase II study of biweekly paclitaxel and cisplatin chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma: ERCC1 expression predicts response to chemotherapy

Jing Huang, Yi Zhou, Hong‐Tu Zhang et al. · Medical Oncology · 2012 · 79 citations

, , +13

Application of ADC measurement in characterization of renal cell carcinomas with different pathological types and grades by 3.0T diffusion-weighted MRI

Xiaoduo Yu, Meng Lin, Han Ouyang et al. · European Journal of Radiology · 2012 · 79 citations

, , +17

Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210

Lanying Ma, Xi Wang, Hongnan Mo et al. · Cancer Biology and Medicine · 2019 · 69 citations · Full text

, , +17

1–5 of 15